Status:
COMPLETED
Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia
Lead Sponsor:
Georgetown University
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to refine and evaluate the Preventing Recurrence of Thromboembolic Events through Coordinated Treatment in the District of Columbia (PROTECT DC) intervention. PROTECT DC i...
Detailed Description
Despite significant advances in the prevention and treatment of cerebrovascular disease in the last few decades, stroke remains the third leading cause of death and the leading cause of adult disabili...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Hospitalized due to ischemic stroke\* or intercurrent ischemic stroke\* event within the past 30 days OR Transient ischemic attack, confirmed by stroke neurologist.
- Atherogenic etiology(large vessel, small vessel, cryptogenic with at least one stroke risk factor, or embolic stroke due to atherogenic cardiac disease) as defined by TOAST criteria.
- Community dwelling prior to stroke
- Resides within the District of Columbia or closely nearby (preferably within 10 miles of the DC border)
- Expected to reside within the District of Columbia or closely nearby (preferably within 10 miles of DC border)
- Caregiver or interested party available, if moderately or severely disabled (not required to actually reside with participant)
- Sufficient number of collateral contacts to assure follow-up. Defined as: Preferred: at least 6 contacts; and No fewer than 3 contacts (unless approved by study PI/co-PI/co-I)
- Judged likely to return to community setting at completion of post-acute care.
Exclusion
- Non-atherogenic cause of stroke
- NIHSS \> 20
- Any medical condition that would limit participation in follow up assessments
- Baseline dementia per informant report (AD8) or screening assessment (Short Blessed Memory Orientation Concentration Test)
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT00703274
Start Date
April 1 2008
End Date
January 1 2013
Last Update
February 21 2013
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown University Hospital
Washington D.C., District of Columbia, United States, 20007
2
National Rehabilitation Hospital
Washington D.C., District of Columbia, United States, 20010
3
Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010
4
Providence Hospital
Washington D.C., District of Columbia, United States, 20017